Hims & Hers Health (HIMS) is trying its best to stay relevant in the multi-billion dollar obesity treatment market. Despite a ...

Morgan Stanley (MS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

JPMorgan lowered the firm’s price target on Morgan Stanley (MS) to $125 from $129 and keeps a Neutral rating on the shares. The firm adjusted ...

Yeti Holdings (YETI, Financials), and Martin Marietta Materials (MLM, Financials) as stocks that could better withstand ...

As "Liberation Day" approaches, the S&P 500 is selling off in anticipation of more tariffs. Investors aren't expecting relief from market volatility once April 2nd tariffs go into effect.

Investment analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for Tenaya Therapeutics in a report issued on ...

Investment analysts at Wedbush reduced their Q3 2025 EPS estimates for shares of Safehold in a research report issued to ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

Speaking during his show Mad Money on CNBC on April 2, Cramer cautioned that markets could experience a carnage akin to that ...

Apple ( AAPL 2.26%) and Tesla ( TSLA -1.29%) are two of the popular stocks among individual investors, but the hedge fund ...